Joseph Aisner

14.7k total citations · 2 hit papers
308 papers, 10.8k citations indexed

About

Joseph Aisner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Joseph Aisner has authored 308 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Oncology, 113 papers in Pulmonary and Respiratory Medicine and 64 papers in Molecular Biology. Recurrent topics in Joseph Aisner's work include Lung Cancer Research Studies (63 papers), Lung Cancer Treatments and Mutations (53 papers) and Cancer Treatment and Pharmacology (47 papers). Joseph Aisner is often cited by papers focused on Lung Cancer Research Studies (63 papers), Lung Cancer Treatments and Mutations (53 papers) and Cancer Treatment and Pharmacology (47 papers). Joseph Aisner collaborates with scholars based in United States, Netherlands and United Kingdom. Joseph Aisner's co-authors include Peter H. Wiernik, Margaret Whitacre, Merrill J. Egorin, David A. Van Echo, Charles A. Schiffer, Bruce E. Johnson, Wiernik Ph, Jean‐Pierre Pignon, Hiroshi Ueoka and Anna Gregor and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Joseph Aisner

302 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

1999 1.2k citations Bruce E. Johnson, Joseph Aisner et al. profile →
Treatment of Invasive Aspergillosis: Relation of Early Diagnosis and Treatment to Response

1977 344 citations Joseph Aisner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph Aisner United States	55	5.2k	3.9k	2.4k	1.9k	1.1k	308	10.8k
Ronald Feld Canada	58	8.0k 1.5×	4.6k 1.2×	3.2k 1.3×	1.7k 0.9×	966 0.9×	247	12.9k
Robert Wesley United States	58	3.2k 0.6×	3.2k 0.8×	3.0k 1.2×	1.6k 0.8×	2.8k 2.5×	158	13.7k
Martin H. Cohen United States	53	5.4k 1.0×	3.5k 0.9×	1.9k 0.8×	3.7k 2.0×	926 0.8×	160	12.5k
David C. Dale United States	74	8.3k 1.6×	2.1k 0.5×	2.0k 0.8×	2.1k 1.2×	1.8k 1.6×	337	19.6k
Xavier Filella Spain	56	2.7k 0.5×	2.7k 0.7×	2.1k 0.9×	2.4k 1.3×	1.2k 1.1×	242	9.2k
Vincent Launay‐Vacher France	40	10.6k 2.0×	4.8k 1.2×	1.3k 0.5×	2.5k 1.4×	1.2k 1.1×	158	16.3k
Paolo Bruzzi Italy	67	5.1k 1.0×	1.7k 0.4×	1.5k 0.6×	2.0k 1.1×	1.7k 1.5×	325	14.3k
Mark F. Munsell United States	64	3.6k 0.7×	2.2k 0.6×	1.5k 0.6×	2.0k 1.1×	2.8k 2.5×	243	11.8k
Vincent T. DeVita United States	61	5.1k 1.0×	3.0k 0.8×	1.6k 0.6×	2.0k 1.1×	1.7k 1.5×	191	14.2k
Emil Frei United States	64	7.3k 1.4×	3.4k 0.9×	1.1k 0.5×	3.1k 1.7×	1.4k 1.2×	272	15.8k

Countries citing papers authored by Joseph Aisner

Since Specialization

Citations

This map shows the geographic impact of Joseph Aisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Aisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Aisner more than expected).

Fields of papers citing papers by Joseph Aisner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Aisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Aisner. The network helps show where Joseph Aisner may publish in the future.

Co-authorship network of co-authors of Joseph Aisner

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Aisner. A scholar is included among the top collaborators of Joseph Aisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Aisner. Joseph Aisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berim, Lyudmyla, et al.. (2021). Combining radiation therapy and immunotherapy for lung cancers: a narrative review. Shanghai Chest. 5. 10–10. 6 indexed citations

Aisner, Joseph, et al.. (2019). Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy. Journal of Surgical Research. 246. 19–25. 16 indexed citations

Malhotra, Jyoti, Salma K. Jabbour, Gregory Riedlinger, et al.. (2019). Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC). Cancer Treatment and Research Communications. 21. 100158–100158. 52 indexed citations

Yegya‐Raman, Nikhil, Joseph Aisner, Sinae Kim, et al.. (2019). Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution. Advances in Radiation Oncology. 4(3). 541–550. 4 indexed citations

Goel, Sanjay, Umang Swami, Christian Dittrich, et al.. (2019). A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 84(3). 567–578. 3 indexed citations

Yegya‐Raman, Nikhil, Kyle Wang, Sinae Kim, et al.. (2018). Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC. Journal of Thoracic Oncology. 13(10). 1508–1518. 76 indexed citations

Malhotra, Jyoti, David Rotter, Salma K. Jabbour, et al.. (2018). Receipt of recommended surveillance with imaging in elderly survivors of early stage non-small cell lung cancer. Lung Cancer. 125. 205–211.

Deek, Matthew P., et al.. (2015). Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(1). 147–154. 48 indexed citations

Aisner, Joseph, Judith Manola, Shaker R. Dakhil, Philip J. Stella, & Joan H. Schiller. (2011). Randomized phase II study of vandetanib (V), docetaxel (D), and carboplatin (C) followed by maintenance V or placebo (P) in patients with stage IIIb, IV, or recurrent non-small cell lung cancer (NSCLC): PrECOG PrE0501—Update on maintenance treatment, progression-free survival (PFS), and overall survival (OS).. Journal of Clinical Oncology. 29(15_suppl). 7560–7560. 4 indexed citations

10.

Tucker, Margaret A., Nevin Murray, Edward G. Shaw, et al.. (1997). Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 89(23). 1782–1788. 167 indexed citations

11.

Aisner, Joseph. (1996). Comprehensive textbook of thoracic oncology. Williams & Wilkins eBooks. 93 indexed citations

12.

Belani, Chandra P., L. Austin Doyle, & Joseph Aisner. (1994). Etoposide: current status and future perspectives in the management of malignant neoplasms. Cancer Chemotherapy and Pharmacology. 34(S1). S118–S126. 73 indexed citations

13.

Parnes, Howard L., Jeffrey S. Abrams, Nancy Tait, et al.. (1991). Phase I/II Study of Cyclophosphamide, Doxorubicin, Fluorouracil, and Leucovorin for Treatment of Metastatic Adenocarcinoma. JNCI Journal of the National Cancer Institute. 83(14). 1017–1020. 5 indexed citations

14.

Budman, Daniel R., Ann H. Korzun, Joseph Aisner, et al.. (1990). A Feasibility Study of Intensive CAF as Outpatient Adjuvant Therapy for Stage II Breast Cancer in a Cooperative Group: CALGB 8443. Cancer Investigation. 8(6). 571–575. 7 indexed citations

15.

Tchekmedyian, N. Simon, Nancy Tait, Marcia R. Moody, & Joseph Aisner. (1986). Weight gain with high dose megestrol acetate a possible treatment for cachexia. 27. 209. 2 indexed citations

16.

Egorin, Merrill J., David A. Van Echo, Margaret Whitacre, et al.. (1985). Human Pharmacokinetics and Correlation With Clinical Toxicities of the Anthracycline Antibiotic Menogaril (7-Omen). Journal of Bioresource Management. 26. 155. 3 indexed citations

17.

Schiffer, Charles A., et al.. (1982). Histocompatible platelet transfusion for patients with leukemia. 3(3). 273–281. 5 indexed citations

18.

Kaplan, Richard, et al.. (1981). PRELIMINARY-OBSERVATIONS ON THE EFFECTS OF DIMETHYLSULFOXIDE ON THE METABOLISM AND DISTRIBUTION OF ADRIAMYCIN. UCL Discovery (University College London). 2 indexed citations

19.

Aisner, Joseph, et al.. (1979). Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(4). 292–9. 15 indexed citations

20.

Aisner, Joseph, et al.. (1979). Streptozotocin: an inactive agent in small cell carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(1). 59–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact